Our vision is enabling effective cancer treatment sooner. BIOARRAY's approach is to confront "cancer in reverse" by focusing on healthy cell organization, not limited to specific patients or treatments. BIOARRAY has developed a proprietary discovery platform leveraging normal cell biology and math to identify novel cancer genes. Markers of healthy cell organization stratify cancer patients by prognosis in independent datasets totaling 699 patients. BIOARRAY's discovery approach can be applied to multiple cancer types including breast, prostate, and pancreatic.